Skip to main content

Table 2 Association between KSHV seropositivity or antibody levels and study population. KSHV seropositivity in children

From: Variation in KSHV prevalence between geographically proximate locations in Uganda

Study Children 1–13 years Children 5 years only
KSHV seropositivity *OR (95% CI), P value KSHV seropositivity **OR (95% CI), P value
EMaBSa 15% (184/1222) 1 15% (184/1222) 1
GPCb 47% (1597/3425) 3.16 (2.38, 4.19), < 0.0001 35% (111/315) 3.08 (2.31, 4.12), < 0.0001
LaVIISWAc 56% (305/513) 5.79 (3.82, 8.77), < 0.0001 54% (37/61) 7.81 (3.67, 16.62), < 0.0001
  1. *Adjusted for age group, sex and HIV serostus ** Adjusted for sex and HIV serostatus. *OR: odds ratio. Logistic regression analysis was used for statistical analysis allowing for the survey design for the LaVIISWA trial. aEMaBS-Entebbe Mother and Baby Study, bGPC-General Population Cohort, cLaVIISWA-Lake Victoria Island Intervention Study on Worms and Allergy related diseases